LUTZ | ABEL RECHTSANWALTS PARTG MBB | View firm profile
Munich, April 2026
LUTZ | ABEL advised the shareholders of Plasmion GmbH, including, inter alia, the founders Dr. Jan-Christoph Wolf and Dr. Thomas Wolf, HTGF, BayBG and Wieland Capital on the sale of a 75% stake in the company to Shimadzu Corporation, a global leader in analytical and measuring instruments headquartered in Japan.
With this transaction, Shimadzu strengthens its presence in the field of advanced analytical technologies and expands its portfolio in innovative mass spectrometry solutions. Plasmion, an Augsburg-based technology company, is known for its pioneering developments in ion mobility spectrometry, particularly its SICRIT® technology, which enables rapid and highly sensitive chemical analysis.
The LUTZ | ABEL team was led by Philipp Hoene (lead partner, Munich) and included Constanze Hachmann (Hamburg), Lars Dieball (Munich) and Frank Hahn (Hamburg, all M&A), as well as Cornelius Renner (IP/IT, Berlin). The firm advised the sellers on all legal aspects of the transaction, including structuring, negotiation and execution.
Founded in 2013, Plasmion has established itself as an innovation leader in the field of compact and efficient ionization technologies. Its solutions are used in a wide range of applications, including environmental analysis, food safety, and pharmaceutical research. Through the partnership with Shimadzu, Plasmion aims to accelerate its international growth and further develop its cutting-edge technology platform.
Shimadzu Corporation, listed on the Tokyo Stock Exchange, is a globally active provider of precision
instruments, medical equipment and industrial machinery.
About LUTZ | ABEL
LUTZ | ABEL as a law firm, with approximately 110 attorneys and offices in Munich, Hamburg, Stuttgart, Berlin, and Frankfurt am Main, provides advice on all matters of commercial law.
For more information, please visit www.lutzabel.com.
Contact LUTZ | ABEL
Philipp Hoene
Partner
+49 89 544147-0
[email protected]
Anne Hofmann
Head of Marketing & Business Development
+49 40 3006996-7701
[email protected]